ADMINISTRATION OF DISULFIDE-STABILIZED FV-IMMUNOTOXINS B1(DSFV)-PE38 AND B3(DSFV)-PE38 BY CONTINUOUS-INFUSION INCREASES THEIR EFFICACY IN CURING LARGE TUMOR XENOGRAFTS IN NUDE-MICE

被引:34
作者
BENHAR, I [1 ]
REITER, Y [1 ]
PAI, LH [1 ]
PASTAN, I [1 ]
机构
[1] NCI, DIV CANC BIOL DIAG & CTR, DEPT BIOL MOLEC, BETHESDA, MD 20892 USA
关键词
D O I
10.1002/ijc.2910620320
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
B1(dsFv)-PE38 and B3(dsFv)-PE38 are recombinant immuno-toxins in which the Fv fragments of MAbs B1 and B3, respectively, are stabilized by an engineered interchain disulfide bond and are fused at their C-termini to a modified Pseudomonas exotoxin from which the cell-binding domain has been deleted (PE38). Both immunotoxins have been shown to be specifically cytotoxic toward human cancer cell lines which express Le(Y)-related carbohydrates on their surface, and when given i.v., eradicated 30- to 50-mm(3) s.c. A431 tumors growing in nude mice. A major advantage of dsFv-immunotoxins is their stability at 37 degrees C compared with the relatively unstable single-chain Fvs. This allows them to be given continuously by osmotic pumps placed in the peritoneal cavity. In an attempt to increase the therapeutic index of the immunotoxins, we have now delivered them continuously for 6 days through mini-osmotic pumps placed in the peritoneal cavity of tumor-bearing nude mice. Using this mode of administration, we were able to maintain a constant level of immunotoxin in the serum which was non-toxic to the mice, but caused complete regressions of large 150- to 200-mm(3) tumors which lasted for over a month at 1/11 of the LD(50) with BI(dsFv)-PE38 and 1/6 of the LD(50) with B3(dsFv)-PE38. Complete regression of tumors of similar size could also be achieved by i.v. bolus injections of these immunotoxins at 1/7 of the LD(50) with B1(dsFv)-PE38 and 1/3 of the LD(50) With B3(dsFv)-PE38. These results suggest that in patients it may be advantageous to administer dsfv-immunotoxins by continuous infusion, since a larger therapeutic index is achieved. (C) 1995 Wiley-Liss, Inc.*
引用
收藏
页码:351 / 355
页数:5
相关论文
共 20 条
[1]  
BENHAR I, 1994, IN PRESS PROTEIN ENG
[2]  
BENHAR I, 1995, IN PRESS CLIN CANCER
[3]   A RECOMBINANT IMMUNOTOXIN CONTAINING A DISULFIDE-STABILIZED FV FRAGMENT [J].
BRINKMANN, U ;
REITER, Y ;
JUNG, SH ;
LEE, B ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (16) :7538-7542
[4]   IMMUNOTOXINS AGAINST CANCER [J].
BRINKMANN, U ;
PASTAN, I .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 1994, 1198 (01) :27-45
[5]   B3(FV)-PE38KDEL, A SINGLE-CHAIN IMMUNOTOXIN THAT CAUSES COMPLETE REGRESSION OF A HUMAN CARCINOMA IN MICE [J].
BRINKMANN, U ;
PAI, LH ;
FITZGERALD, DJ ;
WILLINGHAM, M ;
PASTAN, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (19) :8616-8620
[6]  
JAIN RK, 1990, CANCER RES, V50, pS814
[7]  
JAIN RK, 1988, CANCER RES, V48, P7022
[8]  
JUWEID M, 1992, CANCER RES, V52, P5144
[9]  
KREITMAN RJ, 1994, BLOOD, V83, P426
[10]   ADMINISTRATION OF IL-2-PE40 VIA OSMOTIC PUMPS PREVENTS ADJUVANT INDUCED ARTHRITIS IN RATS - IMPROVED THERAPEUTIC INDEX OF IL-2-PE40 ADMINISTERED BY CONTINUOUS INFUSION [J].
LORBERBOUMGALSKI, H ;
LAFYATIS, R ;
CASE, JP ;
FITZGERALD, D ;
WILDER, RL ;
PASTAN, I .
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1991, 13 (2-3) :305-315